047eur
-0,8 %
Date:2024-03-28Time:17:29:00Latest report:Q2-2022List:First NorthTicker:BONEH
Market Cap:9 meurEnterprise Value:12 meurNet Sales:- meurEarnings:-3,14 meurEmployees:0ISIN:FI4000260583

Ratios

10-year key figure history for BBS-Bioactive Bone turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for BBS-Bioactive Bone with index and moving average MA50 and MA200.

Stockprice:0,47
MA50:0,52
MA200:0,50
Price/MA200:-6,4 %
RSI (14):37,4
Price/MA50:-10,1 %

Description

BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

Medical Equipment